Global Food Allergy Diagnostics and Therapeutics Market, By Product Type (Diagnostics, Therapeutics), By End-Use (Hospitals and Clinics, Diagnostics Laboratories), and Region (North America, Europe, Asia-Pacific, Middle East and Africa, South America) – Market Size and Forecasting to 2030

The Global Food Allergy Diagnostics and Therapeutics Market valued at USD XX billion in 2020 and is expected to grow at a CAGR of XX% over the forecast period.

Increasing prevalence of food allergy is expected to drive the market. Symptoms of food allergy vary from person and commonly symptoms are associated with respiratory tract, cardiovascular system, skin, and gastrointestinal tract. These symptoms are comprised of itchiness, swelling of tongue, or hives to low blood pressure, diarrhea, or vomiting. Thus, more awareness about type of the allergies, proper counseling and knowledge about the risk factors of anaphylaxis is necessary, which is expected to contribute to the market growth during the forecast period.

The increasing number of allergies associated with contaminated food, rising awareness about food allergies, and the introduction of novel products in the market are driving the market growth. Some common allergies are mainly due to eggs, wheat, fish, and milk. There is a high incidence of food allergies mainly due to fish raised in the Asia-Pacific region.

Allergies are known as a response of the immune system of the body to food. According to the published report of Asthma and Allergy Foundation of America 2017, there were 26 million adults and 5.6 million children diagnosed with food allergies. These allergies are mainly caused due to eggs, milk, tree nuts, peanuts, wheat, fish, and shellfish. It mainly affects around 6–8% of children below 5 years and 3% of the adult population. Thus, increasing incidence and rising healthcare expenditure, advanced therapeutics, and diagnostics facilities drive the market growth across the globe.

According to data published by World Allergy Organization in 2017, the rate of prevalence of allergy mainly due to eggs and peanuts among children in the U.K. and Australia was approximately 1.8% and 3.0%, respectively. In September 2019, the Allergenic Products Advisory Committee (APAC) convened by the U.S. Food & Drug Administration (FDA) had provided support to the use of AR101 auto-injector in children having a peanut allergy.

Technological innovations and rising R&D initiatives undertaken for the development of drugs contribute to market growth. EpiPen epinephrine auto-injector is mainly used to treat peanut allergies. However, the higher cost of EpiPen makes it unaffordable for people in low-income countries.

Market Segmentation

Global Food Allergy Diagnostics and Therapeutics Market, by Product Type

Based on product, the market is segmented into diagnostics and therapeutics. The therapeutics segment is expected to drive market growth during the forecast period. The market growth can be due to rising awareness about various treatments and management of food allergies and the introduction of novel therapeutics in the market.

Diagnostics products comprise diagnostics instruments and consumables. The instruments segment is estimated to exhibit profitable growth over the forecast period. The therapeutics segment is further classified into epinephrine auto-injector and antihistamines. Antihistamines are widely used as they act to release histamine. Thus, the therapeutics segment is expected to witness higher growth over the forecast period.

Global Food Allergy Diagnostics and Therapeutics Market, by End-Use

Based on end-use, the market is segmented into hospitals and clinics, and diagnostics laboratories. The hospitals and clinics segment is expected to drive the market growth over the forecast period owing to the rise in the number of people seeking treatment for allergies.

The rising number of allergic cases requiring treatment and growing risk for severe allergic reactions has been increased, thus demand for the treatment in hospitals and clinics is expected to continue to rise. The diagnostic laboratories segment is expected to witness significant growth over the forecast period due to the wide use of allergy diagnostic kits in the diagnosis of the number of allergies. Commonly allergies are associated with food such as eggs, milk, peanut diagnosed with blood or skin test. The increasing number of diagnostic centers is expected to drive the growth of the diagnostic laboratories segment.

Global Food Allergy Diagnostics and Therapeutics Market, by Region

Based on the region, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. North America is expected to be the foremost revenue contributor followed by Europe. According to the published report of Asthma and Allergy Foundation of America 2017, 26 million adults and 5.6 million children were diagnosed with food allergies. According to the European Academy of Allergy and Clinical Immunology, 17 million adults in Europe suffer from food allergies. Thus, owing to the increasing incidence of food allergies, Europe is estimated to witness the highest growth. Increasing awareness about various available treatments for food allergies is expected to contribute to the regional market growth.

Asia-Pacific is estimated to witness profitable growth over the forecast period due to an increase in the number of food allergy cases, especially peanut and fish allergies. Modernization, growing population in the region, and changing lifestyles contribute to the market growth across the region. Along with rising incidence, government support for the production of new biologics and investments from various key market players are expected to augment the market growth during the forecast period.

What does this Report Provide?

A detailed understanding of the global food allergy diagnostics and therapeutics market demand from a qualitative and quantitative perspective with a forecast for the next 10 years. The report also provides dynamic indicators with potential impact on the market during the forecast period and an in-depth analysis of the leading companies operating in the global market.

The major market drivers, challenges, and opportunities for the global food allergy diagnostics and therapeutics market have also been covered in the report. This report further includes the market share of the leading companies operating in the global market, along with their production capacities and the growth strategies adopted by them.

Key Developments

  • In 2017, Stallergenes Greer invested in a research-driven food company Adeo, to build up novel treatments for food allergy

Market Segmentation

By Product

  • Diagnostics (Diagnostics Instruments, Consumables)
  • Therapeutics (Epinephrine, Auto-injector, Antihistamines)

By End-Use

  • Hospitals and Clinics
  • Diagnostics Laboratories

By Region

  • North America Food Allergy Diagnostics and Therapeutics Market
    • By Country (The U.S., Canada, Mexico)
    • By Product
    • By End-Use
  • Europe Food Allergy Diagnostics and Therapeutics Market
    • By Country (Germany, Russia, The U.K., France, Italy, Spain, The Rest of Europe)
    • By Product
    • By End-Use
  • Asia-Pacific Food Allergy Diagnostics and Therapeutics Market
    • By Country (China, Japan, India, South Korea, Australia, The Rest of Asia-Pacific)
    • By Product
    • By End-Use
  • Middle East and Africa Food Allergy Diagnostics and Therapeutics Market
    • By Country (The UAE, Saudi Arabia, Qatar, South Africa, The Rest of Middle East and Africa)
    • By Product
    • By End-Use
  • South America Food Allergy Diagnostics and Therapeutics Market
    • By Country (Brazil, Argentina, The Rest of South America)
    • By Product
    • By End-Use

Major Companies: In this report, the following major companies are studied: Allergy Therapeutics, Astellas Pharma, Inc., Cambridge Allergy Ltd, Prota Therapeutics Pty Ltd, Aimmune Therapeutics, Immunomic Therapeutics, Inc., ALK-Abelló Ltd, and Medeca Pharma AB.

Years Covered in the Study:

Historic Year: 2018-2019

Base Year: 2020

Estimated Year: 2021

Forecast Year: 2030

Objectives of this report:

  • To estimate the market size for the Food allergy diagnostics & therapeutics market on a regional and global basis.
  • To identify major segments in the Food allergy diagnostics & therapeutics market and evaluate their market shares and demand.
  • To provide a competitive scenario for the Food allergy diagnostics & therapeutics market with major developments observed by key companies in the historic years.
  • To evaluate key factors governing the dynamics of the Food allergy diagnostics & therapeutics market with their potential gravity during the forecast period.

Reasons to Buy This Report:

  • Market size estimation of the global food allergy diagnostics and therapeutics market on a regional and global basis
  • Unique research usage for market size estimation and forecast
  • Profiling of major companies operating in the market with key developments
  • Broad scope to cover all the possible segments helping every stakeholder in the market

Customization:

We provide customization of the study to meet specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country

For more information, contact: sales@quincemarketinsights.com